Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
about
Analysis of VEGF--a regulated gene expression in endothelial cells to identify genes linked to angiogenesisCholera toxin regulates a signaling pathway critical for the expansion of neural stem cell cultures from the fetal and adult rodent brainsPI3K/AKT/mTOR Pathway in AngiogenesisIdentification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemiaAngiogenic factors stimulate growth of adult neural stem cellsImbalances in serum angiopoietin concentrations are early predictors of septic shock development in patients with post chemotherapy febrile neutropeniaCirculating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysisMolecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3Angiopoietins 3 and 4: diverging gene counterparts in mice and humansAngiopoietin-1 is an apoptosis survival factor for endothelial cellsHepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosisCharacterization and expression of a novel alternatively spliced human angiopoietin-2Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitroAngiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressureAngiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinomaMultiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cellsBiomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesisAngiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endotheliumVE-PTP controls blood vessel development by balancing Tie-2 activityEffects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surfaceAngiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contactsThe PTEN/PI3K pathway governs normal vascular development and tumor angiogenesisSphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak.CYR61 (CCN1) is essential for placental development and vascular integrityA gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22.Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiationFisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivoBiologic significance of angiopoietin-2 expression in human hepatocellular carcinomaThe orphan nuclear receptor COUP-TFII is required for angiogenesis and heart developmentNeurovascular signals suggest a propagation mechanism for endogenous stem cell activation along blood vesselsKaposi's sarcoma-associated herpesvirus induces rapid release of angiopoietin-2 from endothelial cellsTemporal profile of Src, SSeCKS, and angiogenic factors after focal cerebral ischemia: correlations with angiogenesis and cerebral edemaContrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vesselsVE-statin, an endothelial repressor of smooth muscle cell migrationTargeting neural precursors in the adult brain rescues injured dopamine neuronsThe pregnant sheep as a model for human pregnancyAngiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental developmentHomeobox B3 promotes capillary morphogenesis and angiogenesis
P2860
Q21089934-E21C40DA-3DBF-41D7-B268-236A458C1092Q21091132-E5FFC60C-1B39-43EE-923C-03D28AC8FEE2Q21129332-6A2910F9-5FB3-4ACB-B5A4-28FBACBA27C1Q21132375-BE102E96-CF9E-4B3E-8AFB-258E0223A8C5Q21142642-769AECD3-117E-41A8-83AC-E120319B0650Q21261838-C938EFEC-A07E-4778-8505-F63CF69D3D75Q21559692-6AABD6CF-D4D8-4816-8923-58DC5351DB56Q22008784-5CD54167-30E2-4015-8D3E-EF177AAC0890Q22008836-48CE49AF-E965-4388-A390-5E12044B8A91Q22009457-4465DDE5-FAC0-4F02-B3DB-46697D08BAFEQ22253259-4F669126-3E03-4C7F-B82B-3A2352BCA293Q22253905-4BFA16D2-1202-4245-8D36-A518B4B0A04FQ24291158-6A81A1E8-EC3B-4DAA-8DF5-44CD6BD73CB4Q24294359-8B61D360-C31C-43EB-A18D-161708F5A047Q24300294-3526E000-56A7-48AD-AB13-5779B667DD04Q24300714-7C0535A9-9430-4D61-A282-5D9D8A67377EQ24301574-F716DED2-12FC-4A88-B030-7B8B07698217Q24302790-4C1D7449-756E-4FE5-BDB9-B5DC7238DD6DQ24311749-DB5EBA5F-B5ED-4719-97E8-456972573169Q24311848-1E7AE3E7-55E0-4D05-8C57-4039EF5101F1Q24318368-63EB828F-4106-4D31-970C-A6A19A0A4DE7Q24323888-D63BF68D-D576-4232-9367-8FF23422597EQ24531835-B9C32C76-8EF0-45BE-99CC-57B76AAA2761Q24532043-0D822D22-BD6E-4084-A6CA-13A1F8C84AA0Q24535902-9E191AF8-5296-4B94-805E-DFF6C4734CEDQ24540206-AAF484C3-CD0B-47D1-97E7-BD5E62992BB5Q24540299-2168DC60-43D9-40D0-9677-9F6C070FAD46Q24553023-48914BC8-C04A-4196-94DF-B380A88435E0Q24554513-EAA6D5E7-38D3-4918-AB59-10A0553499A7Q24563486-B5152A3F-6B1B-4FF3-A3C2-3332213DFB8DQ24605541-AC085302-5D22-40A3-AAAB-34706DF2A5B6Q24617068-43D0CB89-C5C1-44ED-9DF7-8B290FBA28F2Q24629364-569EF0AC-347E-4AD3-9120-C03D5617FD1AQ24632012-09EF469C-2C9E-4D99-AF7B-8665AAF77C97Q24644150-D9B4C6D5-DEA6-4C97-8869-9E7CCA296F34Q24644976-045D8093-B8D4-4241-9C87-FE99419A6D4FQ24646096-EEF55A49-87F0-4DEA-8D58-87FF2032F753Q24657385-73DE56AE-A1CB-4D56-B099-FEB734C99A55Q24669641-CCA15DA1-6E6C-455D-A764-71F1A5BF7830Q24670419-8E750F3B-A91B-4351-8919-0C1E79ED8D53
P2860
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
@ast
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
@en
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
@en-gb
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
@nl
type
label
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
@ast
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
@en
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
@en-gb
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
@nl
prefLabel
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
@ast
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
@en
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
@en-gb
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
@nl
P2093
P3181
P1433
P1476
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
@en
P2093
C Radziejewski
G D Yancopoulos
N Papadopoulos
P C Maisonpierre
S Bartunkova
P3181
P356
10.1126/SCIENCE.277.5322.55
P407
P577
1997-07-04T00:00:00Z